On July 10, 2026, Saluda Medical marked a significant milestone by conducting the first surgical procedures in the U.S. with the CAP24™ Paddle Lead. This innovative device has recently received FDA approval, paving the way for its use in clinical settings.
The surgeries were performed by Dr. Erika A. Petersen, a prominent Professor of Neurosurgery at the University of Arkansas for Medical Sciences. Her expertise and leadership in the field have been instrumental in advancing neurosurgical techniques.
The CAP24™ Paddle Lead is designed to enhance patient outcomes in neuromodulation therapies, and its approval represents a crucial step forward in the medical device landscape.